BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36597712)

  • 61. Genetic analysis in a patient presenting with meningioma and familial isolated pituitary adenoma (FIPA) reveals selective involvement of the R81X mutation of the AIP gene in the pathogenesis of the pituitary tumor.
    Guaraldi F; Corazzini V; Gallia GL; Grottoli S; Stals K; Dalantaeva N; Frohman LA; Korbonits M; Salvatori R
    Pituitary; 2012 Dec; 15 Suppl 1():S61-7. PubMed ID: 22527616
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Recent advances in MEN1 gene study for pituitary tumor pathogenesis.
    Kameya T; Tsukada T; Yamaguchi K
    Front Horm Res; 2004; 32():265-91. PubMed ID: 15281352
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Aggressive pituitary adenomas occurring in young patients in a large Polynesian kindred with a germline R271W mutation in the AIP gene.
    Jennings JE; Georgitsi M; Holdaway I; Daly AF; Tichomirowa M; Beckers A; Aaltonen LA; Karhu A; Cameron FJ
    Eur J Endocrinol; 2009 Nov; 161(5):799-804. PubMed ID: 19684062
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mammosomatotroph adenoma of the pituitary associated with gigantism and hyperprolactinemia. A morphological study including immunoelectron microscopy.
    Felix IA; Horvath E; Kovacs K; Smyth HS; Killinger DW; Vale J
    Acta Neuropathol; 1986; 71(1-2):76-82. PubMed ID: 3776476
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A kindred with a variant of multiple endocrine neoplasia type 1 demonstrating frequent expression of pituitary tumors but not linked to the multiple endocrine neoplasia type 1 locus at chromosome region 11q13.
    Stock JL; Warth MR; Teh BT; Coderre JA; Overdorf JH; Baumann G; Hintz RL; Hartman ML; Seizinger BR; Larsson C; Aronin N
    J Clin Endocrinol Metab; 1997 Feb; 82(2):486-92. PubMed ID: 9024241
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Screening for AIP gene mutations in a Han Chinese pituitary adenoma cohort followed by LOH analysis.
    Cai F; Zhang YD; Zhao X; Yang YK; Ma SH; Dai CX; Liu XH; Yao Y; Feng M; Wei JJ; Xing B; Jiao YH; Wei ZQ; Yin ZM; Zhang B; Gu F; Wang RZ
    Eur J Endocrinol; 2013 Dec; 169(6):867-84. PubMed ID: 24050928
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations.
    Georgitsi M; Raitila A; Karhu A; Tuppurainen K; Mäkinen MJ; Vierimaa O; Paschke R; Saeger W; van der Luijt RB; Sane T; Robledo M; De Menis E; Weil RJ; Wasik A; Zielinski G; Lucewicz O; Lubinski J; Launonen V; Vahteristo P; Aaltonen LA
    Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4101-5. PubMed ID: 17360484
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors.
    Marques P; Caimari F; Hernández-Ramírez LC; Collier D; Iacovazzo D; Ronaldson A; Magid K; Lim CT; Stals K; Ellard S; Grossman AB; Korbonits M;
    J Clin Endocrinol Metab; 2020 Jun; 105(6):e2247-60. PubMed ID: 31996917
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A germline c.1546dupC MEN1 mutation in an MEN1 family: A case report.
    Cho YY; Chung YJ
    Medicine (Baltimore); 2021 Jun; 100(25):e26382. PubMed ID: 34160414
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Case report: Management of pediatric gigantism caused by the TADopathy, X-linked acrogigantism.
    Caruso M; Mazzatenta D; Asioli S; Costanza G; Trivellin G; Franke M; Abboud D; Hanson J; Raverot V; Pétrossians P; Beckers A; Cappa M; Daly AF
    Front Endocrinol (Lausanne); 2024; 15():1345363. PubMed ID: 38481440
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical features of multiple endocrine neoplasia type 1 (MEN1) phenocopy without germline MEN1 gene mutations: analysis of 20 Japanese sporadic cases with MEN1.
    Hai N; Aoki N; Shimatsu A; Mori T; Kosugi S
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):509-18. PubMed ID: 10762295
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pituitary tumour causing gigantism. Morphology and in vitro hormone secretion.
    Anniko M; Ritzén EM
    ORL J Otorhinolaryngol Relat Spec; 1986; 48(3):180-90. PubMed ID: 3714202
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Very low frequency of germline GPR101 genetic variation and no biallelic defects with AIP in a large cohort of patients with sporadic pituitary adenomas.
    Lecoq AL; Bouligand J; Hage M; Cazabat L; Salenave S; Linglart A; Young J; Guiochon-Mantel A; Chanson P; Kamenický P
    Eur J Endocrinol; 2016 Apr; 174(4):523-30. PubMed ID: 26792934
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia.
    Occhi G; Trivellin G; Ceccato F; De Lazzari P; Giorgi G; Demattè S; Grimaldi F; Castello R; Davì MV; Arnaldi G; Salviati L; Opocher G; Mantero F; Scaroni C
    Eur J Endocrinol; 2010 Sep; 163(3):369-76. PubMed ID: 20530095
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders.
    Giraud S; Zhang CX; Serova-Sinilnikova O; Wautot V; Salandre J; Buisson N; Waterlot C; Bauters C; Porchet N; Aubert JP; Emy P; Cadiot G; Delemer B; Chabre O; Niccoli P; Leprat F; Duron F; Emperauger B; Cougard P; Goudet P; Sarfati E; Riou JP; Guichard S; Rodier M; Meyrier A; Caron P; Vantyghem MC; Assayag M; Peix JL; Pugeat M; Rohmer V; Vallotton M; Lenoir G; Gaudray P; Proye C; Conte-Devolx B; Chanson P; Shugart YY; Goldgar D; Murat A; Calender A
    Am J Hum Genet; 1998 Aug; 63(2):455-67. PubMed ID: 9683585
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.
    Daly AF; Vanbellinghen JF; Khoo SK; Jaffrain-Rea ML; Naves LA; Guitelman MA; Murat A; Emy P; Gimenez-Roqueplo AP; Tamburrano G; Raverot G; Barlier A; De Herder W; Penfornis A; Ciccarelli E; Estour B; Lecomte P; Gatta B; Chabre O; Sabaté MI; Bertagna X; Garcia Basavilbaso N; Stalldecker G; Colao A; Ferolla P; Wémeau JL; Caron P; Sadoul JL; Oneto A; Archambeaud F; Calender A; Sinilnikova O; Montañana CF; Cavagnini F; Hana V; Solano A; Delettieres D; Luccio-Camelo DC; Basso A; Rohmer V; Brue T; Bours V; Teh BT; Beckers A
    J Clin Endocrinol Metab; 2007 May; 92(5):1891-6. PubMed ID: 17244780
    [TBL] [Abstract][Full Text] [Related]  

  • 77. AIP mutation in pituitary adenomas in the 18th century and today.
    Chahal HS; Stals K; Unterländer M; Balding DJ; Thomas MG; Kumar AV; Besser GM; Atkinson AB; Morrison PJ; Howlett TA; Levy MJ; Orme SM; Akker SA; Abel RL; Grossman AB; Burger J; Ellard S; Korbonits M
    N Engl J Med; 2011 Jan; 364(1):43-50. PubMed ID: 21208107
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Update on familial pituitary tumors: from multiple endocrine neoplasia type 1 to familial isolated pituitary adenoma.
    Daly AF; Tichomirowa MA; Beckers A
    Horm Res; 2009 Jan; 71 Suppl 1():105-11. PubMed ID: 19153518
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pituitary gigantism: Causes and clinical characteristics.
    Rostomyan L; Daly AF; Beckers A
    Ann Endocrinol (Paris); 2015 Dec; 76(6):643-9. PubMed ID: 26585365
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A novel mutation of the MEN1 gene in a Chinese kindred with multiple endocrine neoplasia type 1.
    Xu L; Li X; Feng B; Ni Y; Wang H; Wang L
    Endocr J; 2010; 57(9):839-45. PubMed ID: 20710116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.